2015-11-19 08:00:00
A PDF Version of the Agenda is available here.
| NOVEMBER 19 | |
| 8:40 a.m. – 9:00 a.m. | Welcome and Introduction Piotr Grodzinski, Ph.D. National Cancer Institute, NIH Jerry S.H. Lee, Ph.D. National Cancer Institute, NIH |
| 9:00 a.m. – 12:20 p.m. | Session I Chair: Christina Liu, Ph.D. National Cancer Institute, NIH |
| 9:00 a.m. – 9:30 a.m. | Nanosystems Biology Cancer Center James Heath, Ph.D. California Institute of Technology Center of Cancer Nanotechnology Excellence |
| 9:30 a.m. – 9:50 a.m. | Interdisciplinary Translational Pre/Postdoctoral Program in Cancer Nanotechnology Konstantin Sokolov, Ph.D. University of Texas MD Anderson Cancer Center Cancer Nanotechnology Training Center |
| 9:50 a.m. – 10:10 a.m. | Stroma Breaking Theranostic Nanoparticle for Targeted Pancreatic Cancer Therapy Lily Yang, M.D., Ph.D. Emory University Innovative Research in Cancer Nanotechnology Award |
| 10:10 a.m. – 10:30 a.m. | The Rodent Eye as a Non-Invasive Window for Understanding Cancer Nanotherapeutics Kit Lam, M.D., Ph.D. University of California, Davis Innovative Research in Cancer Nanotechnology Award |
| 10:30 a.m. – 10:45 a.m. | Welcome from NCI Director Douglas Lowy, M.D. National Cancer Institute, NIH |
| 10:45 a.m. – 11:00 a.m. | Break |
| 11:00 a.m. – 11:20 a.m. | Treatment of Glioblastoma Using Chain-like Nanoparticles Efstathios Karathanasis, Ph.D. and Jeremy Rich, M.D. Case Western Reserve University Innovative Research in Cancer Nanotechnology Award |
| 11:20 a.m. – 11:40 a.m. | Carolina Cancer Nanotechnology Training Program (C-CNTP) Andrew Wang, M.D. University of North Carolina at Chapel Hill Cancer Nanotechnology Training Center |
| 11:40 a.m. – 12:10 p.m. | Nucleic Acid-Based Nanoconstructs for the Treatment of Cancer Milan Mrksich, Ph.D. Northwestern University Center of Cancer Nanotechnology Excellence |
| 12:10 p.m. – 12:30 p.m. | UCLA Multifunctional Mesoporous Silica Nanoparticle Platform for Treatment of Pancreas Cancer Andre Nel, M.D., Ph.D. University of California, Los Angeles Innovative Research in Cancer Nanotechnology Award |
| 12:30 p.m. – 1:30 p.m. | Lunch |
| 1:30 p.m. – 5:15 p.m. | Session 2 – Opportunities for Collaboration with NCI in Cancer Nanotechnology Chair: Dorothy Farrell, Ph.D. National Cancer Institute, NIH |
| 1:30 p.m. – 1:45 p.m. | Data Sharing – Tools and Opportunities Stephanie Morris, Ph.D. National Cancer Institute |
| 1:45 p.m. – 2:15 p.m. | The caNanoLab Database Sharon Gaheen Leidos Biomedical Research |
| 2:15 p.m. – 2:45 p.m. | The Nanotechnology Characterization Laboratory Scott McNeil, Ph.D. Frederick National Laboratory for Cancer Research |
| 2:45 p.m. – 3:15 p.m. | The Center for Advancing Preclinical Research Serguei Kozlov, Ph.D. Frederick National Laboratory for Cancer Research |
| 3:15 p.m. – 3:45 p.m. | Break |
| 3:45 p.m. – 4:15 p.m. | Training in Cancer Nanotechnology |
| 4:15 p.m. – 4:45 p.m. | Potential Collaboration Partners at the NCI Center for Cancer Research and the NIH Clinical Center Peter Choyke, M.D., F.A.C.R. Molecular Imaging Program, NCI Center for Cancer Research Bruce Shapiro, Ph.D. Gene Regulation and Chromosome Biology Laboratory, NCI Center for Cancer Research See also poster presentations |
| 4:45 p.m. – 5:15 p.m. | Nanotechnology Startup Challenge in Cancer Rosemarie Truman Center for Advancing Innovation |
| 5:15 p.m. – 5:30 p.m. | Break |
| 5:30 p.m. – 7:00 p.m. | Poster Session Hands-on caNanoLab Submission Training (data coordinators) Coordination and Governance Committee (by invitation only) |
| NOVEMBER 20 | |
| 8:30 a.m. – 12:00 p.m. | Session 3 Chair: Natalie Abrams, Ph.D. National Cancer Institute, NIH |
| 8:30 a.m. – 9:10 a.m. | Keynote Address Nano-ChIP-Seq Chromatin Profiles of Effective Anti-Tumor T Cells Nicholas P. Restifo, M.D. National Cancer Institute, NIH |
| 9:10 a.m. – 9:40 a.m. | MSKCC-Cornell Center for Translation of Cancer Nanomedicines Michelle Bradbury, M.D., Ph.D. and Uli Wiesner, Ph.D. Memorial Sloan Kettering Cancer Center and Cornell University Center of Cancer Nanotechnology Excellence |
| 9:40 a.m. – 10:00 a.m. | Cancer-Translational Nanotechnology Training Program (Cancer-TNT) Jianghong Rao, Ph.D. Stanford University Cancer Nanotechnology Training Center |
| 10:00 a.m. – 10:30 a.m. | Break |
| 10:30 a.m. – 11:00 a.m. | Nano Approaches to Modulate Host Cell Response for Cancer Therapy Leaf Huang, Ph.D. University of North Carolina Chapel Hill Center of Cancer Nanotechnology Excellence |
| 11:00 a.m. – 11:20 a.m. | Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling Hsian-Rong Tseng, Ph.D. and Edwin Posadas, M.D. University of California, Los Angeles Innovative Research in Cancer Nanotechnology Award |
| 11:20 a.m. – 11:40 a.m. | Cancer Nanotechnology Training Program Gayle Woloschak, Ph.D. Northwestern University Cancer Nanotechnology Training Center |
| 11:40 a.m. – 12:00 p.m. | Nanoscale Metal-Organic Frameworks for Light Triggered and X-ray Induced Photodynamic Therapy of Head and Neck Cancer Wenbin Lin, Ph.D. University of Chicago Innovative Research in Cancer Nanotechnology Award |
| 12:00 p.m. – 1:00 p.m. | Lunch |
| 1:00 p.m. – 3::00 p.m. | Session 4 Chair: Christopher Hartshorn, Ph.D. National Cancer Institute, NIH |
| 1:00 p.m. – 1:30 p.m. | Center for Multiple Myeloma Nanotherapy Samuel Achilefu, Ph.D. Washington University in St. Louis Center of Cancer Nanotechnology Excellence |
| 1:30 p.m. – 1:50 p.m. | Targeted Core Shell Nanogels for Triple Negative Breast Cancer Alexander Kabanov, Ph.D. The University of North Carolina at Chapel Hill Innovative Research in Cancer Nanotechnology Award |
| 1:50 p.m. – 2:10 p.m. | T32: Predoctoral and Postdoctoral Training Program in Nanotechnology for Cancer Research Denis Wirtz, Ph.D. Johns Hopkins University Cancer Nanotechnology Training Center |
| 2:10 p.m. – 2:40 p.m. | Center for Cancer Nanotechnology Excellence for Translational Diagnostics (CCNE-TD) Sanjiv Sam Gambhir, M.D., Ph.D. Stanford University Center of Cancer Nanotechnology Excellence |
| 2:40 p.m. – 3:00 p.m. | Summary and Closing Comments Piotr Grodzinski, Ph.D. National Cancer Institute, NIH |
| 3:00 p.m. | Adjournment |
Capital Consulting Corporation